We urge the Food and Drug Administration (FDA) to use the Accelerated Approval pathway for approval and access to safe, effective therapies for Duchenne Muscular Dystrophy – the leading genetic killer of children that impacts 1 out of every 3,500 boys born in the United States. It’s time for the FDA to Say Yes and make this the first generation of Duchenne survivors.
Stay Connected
Sign up for updates straight to your inbox.